Home/India/MarketsArticle
Markets

Eltek reports wider losses in Q2 2026 earnings call due to production inefficiencies

Eltek Ltd. posted a $2.7 million net loss in Q2 2026 due to production issues and currency impacts amid strong demand. The company plans to convert its backlog into sales to boost revenue and profitability.

BRIC Team
By BRIC Team · BRIC.TV
Published Aug 20, 2026 · 3 min read · 109 views
Eltek reports wider losses in Q2 2026 earnings call due to production inefficiencies

Key Takeaways

  • •Eltek reports significant loss in Q2 2026 due to production issues
  • •Revenue declined despite strong demand and solid backlog
  • •Company aims to convert backlog into sales and boost production
  • •Eltek is expanding manufacturing capacity amid raw material challenges

Eltek Ltd. (NASDAQ:ELTK) faced a tough second quarter in 2026, posting a significant loss due to production hiccups and currency swings. Revenue dropped to $11.5 million from $12.5 million the previous year, despite strong demand and a solid backlog.

CEO Eli Yaffe pointed out that the main problem isn't demand but the company's struggle to turn backlog into production and shipments. He remarked, “The challenge we are facing is not demand, but our ability to consistently convert this demand and our backlog into production and shipments at the level we would like.”

Eltek ended the quarter with a gross loss of $1 million, a sharp decline from the $3 million gross profit a year prior. Still, it was an improvement over the $1.8 million loss in the first quarter of 2026, thanks to higher revenue and better selling prices for PCBs.

The operating loss hit $2.5 million, compared to a $1.5 million operating income the year before. Net loss was $2.7 million, or $0.41 per share, a stark contrast to a $400,000 net income, or $0.05 per share, in the second quarter of 2025. EBITDA loss was $1.9 million, down from a positive EBITDA of $1.9 million a year ago.

Chief Financial Officer Ron Freund attributed the drop in gross profitability to lower revenue volumes, production inefficiencies, and the U. S. dollar's depreciation against the Israeli shekel. Financial expenses fell to $700,000 from $1 million last year, mainly due to the dollar's depreciation, offset by interest income on cash balances.

During the earnings call, management highlighted the market's competitive nature, explaining that Eltek can't significantly raise prices without considering competitors. Freund emphasized the immediate goal of converting backlog into sales and boosting revenue beyond the first half's figures.

Yaffe disclosed that about a third of the backlog is tied to long-term purchase orders based on historical exchange rates, affecting profitability until fulfilled. Another third is linked to exchange rates around 3.2, while the last third, priced closer to the current rate of about 3.0, is the most profitable.

Eltek is working to expand manufacturing capacity with new plating lines and workforce enhancements. A new PCB plating line is undergoing acceptance testing, with formal customer qualification set for the third quarter. Another line is under construction in Europe, slated for installation in Israel by the end of 2026.

Yaffe noted that the supplier for the second line faces penalties due to delays. The company has also integrated about 15 foreign employees, aiming to recruit another 15 to boost production capacity and efficiency.

Raw material availability remains challenging, especially for fiberglass-based materials, which are also sought after by the AI sector. Eltek has secured enough materials to keep operations running, requiring close coordination with suppliers amid rising prices and quotas.

Beyond its defense business, Eltek is eyeing growth in the medical and high-end industrial markets. The company has secured medical sector certifications, positioning itself for future demand, while the high-end industrial sector continues to show strong demand.

Despite the quarterly net loss, Eltek generated $700,000 in cash from operations. As of June 30, the company had $11.5 million in cash and cash equivalents, with no debt. Yaffe expressed confidence that boosting production volumes, improving efficiency, and better material availability could help the company return to past profitability levels over time.

About Eltek: Eltek Ltd. manufactures and sells printed circuit boards (PCBs) in various regions, including Israel, Europe, North America, and India. The company specializes in custom-designed PCBs, including rigid, double-sided, and multi-layer boards, serving industries like medical technology, defense, aerospace, and telecommunications.

#business

Related Articles

Denis Matsuev performs at Mariinsky Theatre during EEF 2026 in Vladivostok

Denis Matsuev performs at Mariinsky Theatre during EEF 2026 in Vladivostok

Denis Matsuev performed with the Russian National Youth Symphony Orchestra at the Mariinsky Theatre during the Eastern Economic Forum in Vladivostok. The event, part of a broader cultural program, underscores the EEF's role in promoting the Russian Far East's economic and cultural development.

Daniel Brown

Oct 5, 2026•10 views
Brazil central government records R$13.585 billion primary deficit in August

Brazil central government records R$13.585 billion primary deficit in August

Brazil's central government reported a primary deficit of R$13.585 billion in August 2025, the largest for the month since 2021. This deficit impacts fiscal targets and investor sentiment.

Rahul Sharma

Oct 5, 2026•10 views
Wealthy Cuban Americans plan for post-regime investments in Cuba

Wealthy Cuban Americans plan for post-regime investments in Cuba

Wealthy Cuban Americans in Miami, led by Juan Omar Sixto, are making plans for potential regime change in Cuba, including proposals for economic initiatives. However, skepticism persists on the island, where economic reforms are seen as inadequate, and shortages and blackouts continue.

James Whiteson

Oct 5, 2026•13 views
Akeso shares jump as AstraZeneca invests $2 billion in cancer drug

Akeso shares jump as AstraZeneca invests $2 billion in cancer drug

Akeso shares jumped over 15% on September 29, 2023, after AstraZeneca committed USD2 billion to support the cancer drug ivonescimab. This strategic investment aims to accelerate global clinical trials, enhancing Akeso's market presence.

Shagun Pandey

Oct 5, 2026•9 views
Oil Prices Rise Amid Stalled US-Iran Negotiations

Oil Prices Rise Amid Stalled US-Iran Negotiations

Oil prices have increased as US-Iran talks stalled. The slowdown in shipping through the Strait of Hormuz and flight disruptions in the UAE highlight the conflict's regional impact.

Daniel Brown

Oct 5, 2026•15 views
Flávio Bolsonaro leads Brazil election, faces Lula in October run-off

Flávio Bolsonaro leads Brazil election, faces Lula in October run-off

Flávio Bolsonaro took 47% in Brazil's presidential election first round, setting up a run-off against Lula da Silva on 25 October. The election could steer Brazil closer to US policies amid a regional shift toward right-wing leadership.

James Whiteson

Oct 5, 2026•14 views